Controlled Release of Anti-inflammatory siRNA from Biodegradable Polymeric Microparticles Intended for Intra-articular Delivery to the Temporomandibular Joint
- First Online:
- Cite this article as:
- Mountziaris, P.M., Sing, D.C., Chew, S.A. et al. Pharm Res (2011) 28: 1370. doi:10.1007/s11095-010-0354-9
- 365 Downloads
As the next step in the development of an intra-articular controlled release system to treat painful temporomandibular joint (TMJ) inflammation, we developed several biodegradable poly(DL-lactic-co-glycolic acid) (PLGA)-based microparticle (MP) formulations encapsulating a model anti-inflammatory small interfering RNA (siRNA) together with branched poly(ethylenimine) (PEI) as a transfecting agent. The effect of siRNA loading and N:P ratio on the release kinetics of siRNA-PEI polyplexes was determined, and the size and N:P ratio of the polyplexes released over time was characterized.
Polyplex-loaded PLGA MPs were prepared using an established double emulsion technique. Increasing the pH of the release samples enabled siRNA-PEI dissociation and subsequent measurement of the release of each component over 28 days. Polyplex diameter was measured for all release samples and compared to freshly prepared siRNA-PEI under simulated physiologic conditions.
Systematic variation of siRNA loading and N:P ratio resulted in distinct siRNA and PEI release profiles. Polyplex diameter remained constant despite large variations in the relative amounts of siRNA and PEI. Excess PEI was sequestered through complexation with 500–1,000 nm diameter PLGA MP-derived particles, including small MPs and PLGA degradation products.
These PLGA MP formulations show exciting potential as the first intra-articular TMJ controlled release system.
KEY WORDSintra-articular microparticle polyplex temporomandibular joint
- anti-TNF-α siRNA
siRNA targeting TNF-α
dynamic light scattering
- N:P ratio
small interfering RNA
tumor necrosis factor-α